tiprankstipranks
Trending News
More News >
NextCell Pharma AB (SE:NXTCL)
:NXTCL
Sweden Market

NextCell Pharma AB (NXTCL) Income Statement

Compare
0 Followers

NextCell Pharma AB Income Statement

Last quarter (Q2 2025), NextCell Pharma AB's total revenue was kr3.25M, an increase of 39.17% from the same quarter last year. In Q2, NextCell Pharma AB's net income was kr-8.20M. See NextCell Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
kr 10.66Mkr 10.11Mkr 5.59Mkr 3.91Mkr 3.56M
Gross Profit
kr -4.56Mkr -884.83Kkr -22.26Mkr -14.53Mkr -10.37M
Operating Expenses
kr 38.61Mkr 40.12Mkr 12.76Mkr 10.38Mkr 7.33M
Depreciation and Amortization
kr 974.67Kkr 447.88Kkr 457.34Kkr 437.02Kkr 397.10K
EBITDA
kr -40.99Mkr -39.36Mkr -34.10Mkr -24.21Mkr -17.28M
Operating Income
kr -43.17Mkr -41.00Mkr -35.02Mkr -24.82Mkr -17.70M
Other Income/Expenses
kr 1.21Mkr 1.19Mkr 469.57Kkr 264.27Kkr 21.67K
Pretax Income
kr -41.96Mkr -39.81Mkr -34.55Mkr -24.56Mkr -17.68M
Net Income
kr -41.96Mkr -39.81Mkr -34.08Mkr -24.56Mkr -17.69M
Per Share Metrics
Basic EPS
kr -0.57kr -0.58kr -0.50kr -0.40kr -0.44
Diluted EPS
kr -0.57kr -0.58kr -0.50kr -0.40kr -0.44
Weighted Average Shares Outstanding
73.09M 68.76M 68.76M 60.82M 39.73M
Weighted Average Shares Outstanding (Diluted)
73.09M 68.76M 68.76M 60.82M 39.73M
Currency in SEK

NextCell Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis